Discover
Aging-US
Aging-US
Author: Aging Podcast
Subscribed: 7Played: 222Subscribe
Share
© All rights reserved
Description
Aging is dedicated to advancing our understanding of the biological mechanisms that drive aging and the development of age-related diseases. Our mission is to serve as a platform for high-quality research that uncovers the cellular, molecular, and systemic processes underlying aging, and translates these insights into strategies to extend healthspan and delay the onset of chronic disease.
Read about the Aging Scientific Integrity Process: https://aging-us.com/scientific-integrity
Read about the Aging Scientific Integrity Process: https://aging-us.com/scientific-integrity
705 Episodes
Reverse
The Future of Aging Research (FAR) Mixer 2026, brought together prominent researchers, biotechnology founders, and industry leaders for discussions on the future of longevity science. The event explored how advances in artificial intelligence (AI), genomics, immunology, and therapeutic development are creating new opportunities to understand biological aging and translate scientific discoveries into interventions that improve human health.
Speakers included Moderna and Soufflé Therapeutics cofounder Robert Langer, ScD; Tolerance Bio CEO Francisco Leon, PhD; MIT and Broad Institute researcher Manolis Kellis; cardiovascular researcher and Director of Cardiac MRI at Beth Israel Deaconess Medical Center (BIDMC) Connie Tsao, MD; and Retro Biosciences founder and CEO Joe Betts-Lacroix. A panel featuring representatives from Pfizer, Flagship Pioneering, and Loyal examined the biotechnology and biopharmaceutical industry’s evolving approach to targeting aging.
Across the presentations and discussions, several themes emerged: the importance of understanding the biological mechanisms underlying aging, the potential of AI to accelerate therapeutic discovery, the need for better measures of healthspan, and the growing role of biotechnology companies in translating research into clinical applications.
Full mixer recap - https://aging-us.org/2026/11/the-future-of-aging-research-scientists-and-biotech-leaders-explore-next-frontier-of-longevity/
Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts
To learn more about the journal, please visit https://www.Aging-US.com and connect with us on social media at:
Bluesky - https://bsky.app/profile/aging-us.bsky.social
ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589
X - https://twitter.com/AgingJrnl
Facebook - https://www.facebook.com/AgingUS/
Instagram - https://www.instagram.com/agingjrnl/
LinkedIn - https://www.linkedin.com/company/aging/
Reddit - https://www.reddit.com/user/AgingUS/
Pinterest - https://www.pinterest.com/AgingUS/
YouTube - https://www.youtube.com/@Aging-US
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc
[email protected]
BUFFALO, NY — November 17, 2026 — A new #research paper was #published in Volume 18 of Aging on November 3, 2026, titled “Brain glucose metabolism and blood-brain barrier permeability in Alzheimer’s disease continuum.”
The study examines the relationship between blood-brain barrier integrity and brain glucose metabolism in Alzheimer’s disease. Researchers found that patients with different Alzheimer’s biomarker profiles showed similar patterns of reduced brain metabolism, but the biological factors associated with these changes differed between groups.
The study’s first author is Francesco Ricci, affiliated with the the Non Invasive Brain Stimulation Unit at IRCCS Santa Lucia and the Dementia Center at Policlinico Tor Vergata, University of Rome Tor Vergata, Italy. The corresponding author is Alessandro Martorana, affiliated with the Dementia Center at Policlinico Tor Vergata, University of Rome Tor Vergata, Italy.
Alzheimer’s disease is characterized by the accumulation of amyloid-beta and tau proteins in the brain, which contribute to neuronal dysfunction and cognitive decline. However, not all patients show the same biological patterns, suggesting that different mechanisms may contribute to disease progression.
The blood-brain barrier is a protective system that regulates the movement of substances between the bloodstream and brain tissue. When its function is impaired, changes in vascular permeability and the brain’s internal environment may affect neuronal health and glucose metabolism.
To investigate these relationships, researchers analyzed 66 patients along the Alzheimer’s disease continuum and 41 cognitively healthy controls. The patients were divided into two groups based on biomarkers of amyloid accumulation, tau pathology and neurodegeneration. One group showed evidence of all three abnormalities, while the other had amyloid pathology and neurodegeneration without elevated phosphorylated tau.
Full press release - https://www.aging-us.com/news-room/blood-brain-barrier-dysfunction-linked-to-altered-brain-metabolism-in-alzheimers-disease
DOI - https://doi.org/10.18632/aging.206393
Corresponding author - Alessandro Martorana - [email protected]
Abstract video - https://www.youtube.com/watch?v=pPVIGcjWhqg
Sign up for free Altmetric alerts about this article -
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206393
Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts
Keywords - aging, Alzheimer’s disease continuum, AD biomarkers, blood-brain-barrier, brain metabolism, FDG-PET
To learn more about the journal, please visit https://www.Aging-US.com and connect with us on social media at:
Bluesky - https://bsky.app/profile/aging-us.bsky.social
ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589
X - https://twitter.com/AgingJrnl
Facebook - https://www.facebook.com/AgingUS/
Instagram - https://www.instagram.com/agingjrnl/
LinkedIn - https://www.linkedin.com/company/aging/
Reddit - https://www.reddit.com/user/AgingUS/
Pinterest - https://www.pinterest.com/AgingUS/
YouTube - https://www.youtube.com/@Aging-US
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc
[email protected]
Each month, we will highlight a paper published in Aging chosen as the “Editors’ Choice.” These selections are handpicked by our editors and accompanied by a brief summary, showcasing research with significant impact and novel insights in aging and age-related diseases.
__________
This month’s Editors’ Choice, “Investigating the efficacy and toxicity of partial in vivo reprogramming as a rejuvenation intervention,” examines the potential benefits and risks of partial cellular reprogramming as an approach to rejuvenation.
Analyzing gene expression data from the liver, kidney, and spleen of aged mice, the researchers identified tissue-specific responses, including reduced age-related inflammation and improved metabolic pathway activity in the liver and kidney. However, findings in the spleen suggested increased cellular proliferation and potential genomic stress, highlighting important safety considerations.
This study underscores the need for further research to better understand the long-term effects and safety of partial reprogramming as a potential aging intervention.
DOI - https://doi.org/10.18632/aging.206431
Corresponding author - Franziska Meiners - [email protected]
Abstract video - https://www.youtube.com/watch?v=hH518dZDq88
Sign up for free Altmetric alerts about this article -
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206431
Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts
Keywords - aging, partial reprogramming, rejuvenation, adverse outcome pathways, metabolism
To learn more about the journal, please visit https://www.Aging-US.com and connect with us on social media at:
Bluesky - https://bsky.app/profile/aging-us.bsky.social
ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589
X - https://twitter.com/AgingJrnl
Facebook - https://www.facebook.com/AgingUS/
Instagram - https://www.instagram.com/agingjrnl/
LinkedIn - https://www.linkedin.com/company/aging/
Reddit - https://www.reddit.com/user/AgingUS/
Pinterest - https://www.pinterest.com/AgingUS/
YouTube - https://www.youtube.com/@Aging-US
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc
[email protected]
BUFFALO, NY — November 12, 2026 — A new #research paper was #published in Volume 18 of Aging on October 27, 2026, titled “Investigating the efficacy and toxicity of partial in vivo reprogramming as a rejuvenation intervention.”
The study examines how partial cellular reprogramming, an experimental approach aimed at reversing certain age-related changes, affects different organs. Researchers found potentially beneficial molecular changes in the liver and kidneys of aged mice, alongside signals in the spleen that raise concerns about the intervention’s long-term safety.
The paper’s first and corresponding author is Franziska Meiners, affiliated with the Institute for Biostatistics and Informatics in Medicine and Ageing Research at University Medical Center Rostock, Germany.
Partial reprogramming has emerged as a potential rejuvenation strategy by temporarily activating proteins known as Yamanaka factors. These proteins can alter gene activity and may help restore some youthful cellular characteristics. However, concerns remain about possible adverse effects, including uncontrolled cell proliferation and genomic instability.
To investigate these effects, the researchers reanalyzed previously published gene-expression data from the liver, kidneys and spleen of aged mice that had undergone seven months of partial reprogramming. They used the Adverse Outcome Pathway framework to examine molecular changes associated with potential benefits and risks.
The analysis revealed different responses across the three organs. In the liver and kidneys, partial reprogramming was associated with reduced expression of inflammation-related genes and increased expression of genes involved in metabolic pathways that typically decline with age.
Full press release - https://www.aging-us.com/news-room/partial-reprogramming-linked-to-tissue-specific-rejuvenation-signals-and-potential-risks
DOI - https://doi.org/10.18632/aging.206431
Corresponding author - Franziska Meiners - [email protected]
Abstract video - https://www.youtube.com/watch?v=hH518dZDq88
Sign up for free Altmetric alerts about this article -
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206431
Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts
Keywords - aging, partial reprogramming, rejuvenation, adverse outcome pathways, metabolism
To learn more about the journal, please visit https://www.Aging-US.com and connect with us on social media at:
Bluesky - https://bsky.app/profile/aging-us.bsky.social
ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589
X - https://twitter.com/AgingJrnl
Facebook - https://www.facebook.com/AgingUS/
Instagram - https://www.instagram.com/agingjrnl/
LinkedIn - https://www.linkedin.com/company/aging/
Reddit - https://www.reddit.com/user/AgingUS/
Pinterest - https://www.pinterest.com/AgingUS/
YouTube - https://www.youtube.com/@Aging-US
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc
[email protected]
BUFFALO, NY — November 10, 2026 — A new #research perspective was #published in Volume 18 of Aging on October 20, 2026, titled “From hyperfunction to systemic amplification: reframing the logic of late-life rejuvenation.”
The paper proposes a new framework for understanding why aging accelerates later in life and how future rejuvenation strategies could address this decline. Rather than focusing only on molecular damage accumulating within individual cells, the author suggests that communication between cells and organs plays a central role in amplifying age-related changes throughout the body.
The research perspective was authored by Pierre-Edouard Sottas, who is affiliated with the xLongevity Center in Vevey, Switzerland.
Aging is commonly understood as the gradual accumulation of cellular damage, including DNA alterations, mitochondrial dysfunction and changes in gene regulation. However, this explanation does not fully account for why functional decline and mortality risk often accelerate sharply in later life.
Building on the hyperfunction theory developed by Mikhail Blagosklonny, the paper explores how biological processes that support growth, repair and survival earlier in life can become harmful when their activity persists or becomes excessive.
Sottas introduces an integrative-first load–gain framework that distinguishes between two components of aging. The first, known as the damage load, represents molecular damage that gradually accumulates within cells. The second, systemic gain, describes how communication networks throughout the body can amplify the effects of that damage.
According to the proposed framework, inflammatory signals, immune and hormonal changes, and extracellular vesicles can spread stress-related messages between cells and tissues. When these signals become persistent and self-reinforcing, they could contribute to the accelerated decline associated with advanced age.
The perspective draws on research involving plasma exchange, extracellular vesicle-based interventions and cellular reprogramming to explore how changes in the body’s internal environment can influence aging-related processes across multiple tissues.
Full press release - https://www.aging-us.com/news-room/new-aging-framework-shifts-focus-of-late-life-rejuvenation-to-systemic-signaling
DOI - https://doi.org/10.18632/aging.206430
Corresponding author - Pierre-Edouard Sottas - [email protected]
Abstract video - https://www.youtube.com/watch?v=70YD8siv7Yc
Sign up for free Altmetric alerts about this article -
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206430
Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts
Keywords - aging, hyperfunction, antagonistic pleiotropy, systemic amplification, Gompertzian mortality, senescence-associated signaling
To learn more about the journal, please visit https://www.Aging-US.com and connect with us on social media at:
Bluesky - https://bsky.app/profile/aging-us.bsky.social
ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589
X - https://twitter.com/AgingJrnl
Facebook - https://www.facebook.com/AgingUS/
Instagram - https://www.instagram.com/agingjrnl/
LinkedIn - https://www.linkedin.com/company/aging/
Reddit - https://www.reddit.com/user/AgingUS/
Pinterest - https://www.pinterest.com/AgingUS/
YouTube - https://www.youtube.com/@Aging-US
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc
[email protected]








